Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Journal of Reconstructive Microsurgery
|
September 17, 2021
Evolution and Transformation of Uterine Transplantation: A Systematic Review of Surgical Techniques and Outcomes
Joseph M Escandón, Valeria P Bustos, Eric Santamaría, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 21, 2024
Identification of circulating tumor cells captured by the FDA-cleared Parsortix<sup>®</sup> PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations
Mariacristina Ciccioli, Kyukwang Kim, Negar Khazan, et al.
Gynecologic Oncology
|
September 15, 2015
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass
Elizabeth Lokich, Marguerite Palisoul, Nicole Romano, et al.
Scientific Reports
|
February 26, 2020
Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines
Kyu Kwang Kim, Rakesh K Singh, Negar Khazan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 27, 2021
Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors
Alexandra Blackman, Jessica Mitchell, Rachael Rowswell-Turner, et al.
Gynecologic Oncology
|
October 15, 2008
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G Moore, D Scott McMeekin, Amy K Brown, et al.
American Journal of Obstetrics and Gynecology
|
May 18, 2010
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, et al.
Gynecologic Oncology
|
December 7, 2007
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G Moore, Amy K Brown, M Craig Miller, et al.
Cancers
|
March 13, 2024
Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer
Kyukwang Kim, Negar Khazan, Rachael B Rowswell-Turner, et al.
Oncotarget
|
May 21, 2019
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins
Nicole E James, Evelyn Cantillo, Naohiro Yano, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Journal of Reconstructive Microsurgery
|
September 17, 2021
Evolution and Transformation of Uterine Transplantation: A Systematic Review of Surgical Techniques and Outcomes
Joseph M Escandón, Valeria P Bustos, Eric Santamaría, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 21, 2024
Identification of circulating tumor cells captured by the FDA-cleared Parsortix<sup>®</sup> PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations
Mariacristina Ciccioli, Kyukwang Kim, Negar Khazan, et al.
Gynecologic Oncology
|
September 15, 2015
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass
Elizabeth Lokich, Marguerite Palisoul, Nicole Romano, et al.
Scientific Reports
|
February 26, 2020
Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines
Kyu Kwang Kim, Rakesh K Singh, Negar Khazan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 27, 2021
Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors
Alexandra Blackman, Jessica Mitchell, Rachael Rowswell-Turner, et al.
Gynecologic Oncology
|
October 15, 2008
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G Moore, D Scott McMeekin, Amy K Brown, et al.
American Journal of Obstetrics and Gynecology
|
May 18, 2010
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, et al.
Gynecologic Oncology
|
December 7, 2007
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G Moore, Amy K Brown, M Craig Miller, et al.
Cancers
|
March 13, 2024
Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer
Kyukwang Kim, Negar Khazan, Rachael B Rowswell-Turner, et al.
Oncotarget
|
May 21, 2019
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins
Nicole E James, Evelyn Cantillo, Naohiro Yano, et al.
Page
of 12